Heron Therapeutics Inc (HRTX)
2.54
+0.21
(+9.01%)
USD |
NASDAQ |
May 02, 16:00
2.50
-0.04
(-1.57%)
After-Hours: 19:03
Heron Therapeutics Cash from Operations (TTM): -58.79M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -58.79M |
| September 30, 2023 | -98.78M |
| June 30, 2023 | -126.66M |
| March 31, 2023 | -127.87M |
| December 31, 2022 | -146.91M |
| September 30, 2022 | -154.64M |
| June 30, 2022 | -170.74M |
| March 31, 2022 | -205.36M |
| December 31, 2021 | -203.35M |
| September 30, 2021 | -210.65M |
| June 30, 2021 | -199.54M |
| March 31, 2021 | -193.82M |
| December 31, 2020 | -184.82M |
| September 30, 2020 | -159.24M |
| June 30, 2020 | -142.66M |
| March 31, 2020 | -108.49M |
| December 31, 2019 | -124.58M |
| September 30, 2019 | -131.09M |
| June 30, 2019 | -141.50M |
| March 31, 2019 | -179.12M |
| December 31, 2018 | -191.80M |
| September 30, 2018 | -205.47M |
| June 30, 2018 | -210.13M |
| March 31, 2018 | -181.43M |
| December 31, 2017 | -170.30M |
| Date | Value |
|---|---|
| September 30, 2017 | -161.67M |
| June 30, 2017 | -157.25M |
| March 31, 2017 | -152.33M |
| December 31, 2016 | -134.10M |
| September 30, 2016 | -118.73M |
| June 30, 2016 | -102.50M |
| March 31, 2016 | -91.21M |
| December 31, 2015 | -78.53M |
| September 30, 2015 | -68.23M |
| June 30, 2015 | -67.58M |
| March 31, 2015 | -64.24M |
| December 31, 2014 | -60.28M |
| September 30, 2014 | -57.05M |
| June 30, 2014 | -50.17M |
| March 31, 2014 | -48.52M |
| December 31, 2013 | -40.76M |
| September 30, 2013 | -37.26M |
| June 30, 2013 | -27.71M |
| March 31, 2013 | -20.86M |
| December 31, 2012 | -17.01M |
| September 30, 2012 | -13.36M |
| June 30, 2012 | -13.21M |
| March 31, 2012 | -10.80M |
| December 31, 2011 | -7.721M |
| September 30, 2011 | -6.166M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-210.65M
Minimum
Sep 2021
-58.79M
Maximum
Dec 2023
-152.08M
Average
-146.91M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| United Therapeutics Corp | 978.00M |
| Esperion Therapeutics Inc | -135.49M |
| Aldeyra Therapeutics Inc | -30.33M |
| Ocular Therapeutix Inc | -70.23M |
| Clearside Biomedical Inc | -18.14M |